News About: Pharm. Industry
Green Cross targets W10 billion in child's nutrition market
Green Cross Corporation plan to target the annual sales of its nutrient product Tirano Gold up to 10 billion won, now that it is becoming popular among young housewives.
According to a company official, the three-...
Patent dispute on Ultracet seen intensifying
With 10 local pharmaceutical firms filing their nullification trial over Ultracet (tramadol HCl + acetaminophen) of Janssen Korea, Hanmi Pharm has also followed the suit with its revised patent on November 8.
Ultr...
Korean scientists invent new photosensitizer synthesizing method
A group of Korean scientists led by Chonnam University have successfully developed a method of synthesizing 'transdermally available 5-amino-levulinic acid (5-ALA) unsaturated alkyl ester and its pharmaceutically acce...
Korea likely to face foreign competition in generic drug market
Indian generic markers will be poised to enter the Korean pharmaceutical market as situation will permit, market experts said.
They argued that the Korea-U.S. free trade agreement is expected to make it easier for ...
Ildong gets exclusive right for paclitaxel PM technology
Ildong Pharm has recently obtained an exclusive license for developing paclitaxel PM product and its delivery system in a strategic partnership with a Chinese company that received a Chinese patent in January of this ...
Foreign drug makers fear disgraced corporate image over rebate scandal
With the Fair Trade Commission's second announcement of rebate scandal involving several foreign-invested pharmaceutical firms, there are growing concerns that the commission's disclosure will tarnish the reliability ...
KPTA calls for delay of drug standard code after 2009
The Korea Pharmaceutical Manufacturers Association has asked the Ministry of Health and Welfare to defer the government's standardized drug bar-code (KD code) plan after 2009.
The association said in a statement th...
LG Life Sciences and Gilead to develop novel drug candidate caspase inhibitor
LG Life Sciences says that it signed with Gilead Sciences, Inc. of the United States an exclusive license agreement focused on the development of caspase inhibitors for the treatment of fibrotic diseases. The agreemen...
OTC-oriented product manager gaining popularity
A growing number of domestic and foreign-invested pharmaceutical firms are struggling to hire long-career product managers who are chiefly dealing with over-the-counter (OTC) drugs, as part of their efforts to cope wi...
Battle looms over CoQ10 market
Coenzyme Q10 (CoQ10) makers are set for a fresh battle for leadership in the domestic market.
Green Cross Corporation will soon tap the CoQ10 market and go on the offensive by forming a joint collaboration with Mit...
